<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/tpj/current_issue/rss">
<title>The Pharmacogenomics Journal - Issue - nature.com science feeds</title>
<description>The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications.</description>
<link>http://www.nature.com/tpj/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights> Copyright
                    ©  Nature Publishing Group</dc:rights>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:issn>1470-269X</prism:issn>
<prism:copyright> Copyright
                    ©  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/aj/images/logos_b_o_w/tpj.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.35" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.47" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.36" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.28" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.31" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.23" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.26" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/tpj.2009.22" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.nature.com/tpj/rss/current" type="application/rss+xml" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /></channel>
<image rdf:about="http://www.nature.com/aj/images/logos_b_o_w/tpj.gif">
<title>The Pharmacogenomics Journal</title>
<url>http://www.nature.com/aj/images/logos_b_o_w/tpj.gif</url>
<link>http://www.nature.com/tpj/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.35">
<title>Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/8w3dEaCIt0k/tpj.2009.35</link>
<content:encoded><![CDATA[
            
<p>
<b>Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches</b>
</p>
<p>The Pharmacogenomics Journal 9,
                355 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.35">doi:10.1038/tpj.2009.35</a>
</p>
<p>Author: F Mannello</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/8w3dEaCIt0k" height="1" width="1"/>]]></content:encoded>
<dc:title>Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches</dc:title>
<dc:creator>F Mannello</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.35</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 355 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>July 28, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.35</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.35</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>355</prism:startingPage>
<prism:endingPage>357</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.35</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.47">
<title>The 8th Annual Pharmacogenetics in Psychiatry Meeting Report</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/9j0HxHj8qOE/tpj.2009.47</link>
<content:encoded><![CDATA[
            
<p>
<b>The 8th Annual Pharmacogenetics in Psychiatry Meeting Report</b>
</p>
<p>The Pharmacogenomics Journal 9,
                358 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.47">doi:10.1038/tpj.2009.47</a>
</p>
<p>Authors: K Aitchison, A Serretti, D Goldman, S Curran, A Drago
                    &amp; A K Malhotra</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/9j0HxHj8qOE" height="1" width="1"/>]]></content:encoded>
<dc:title>The 8th Annual Pharmacogenetics in Psychiatry Meeting Report</dc:title>
<dc:creator>K Aitchison</dc:creator>
<dc:creator>A Serretti</dc:creator>
<dc:creator>D Goldman</dc:creator>
<dc:creator>S Curran</dc:creator>
<dc:creator>A Drago</dc:creator>
<dc:creator>A K Malhotra</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.47</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 358 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>October 20, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.47</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.47</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>358</prism:startingPage>
<prism:endingPage>361</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.47</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.36">
<title>Application of principal component analysis to pharmacogenomic studies in Canada</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/ZLodErlj6Pc/tpj.2009.36</link>
<content:encoded><![CDATA[
            
<p>
<b>Application of principal component analysis to pharmacogenomic studies in Canada</b>
</p>
<p>The Pharmacogenomics Journal 9,
                362 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.36">doi:10.1038/tpj.2009.36</a>
</p>
<p>Authors: H Visscher, C J D Ross, M-P Dub&#233;, A M K Brown, M S Phillips, B C Carleton
                    &amp; M R Hayden</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/ZLodErlj6Pc" height="1" width="1"/>]]></content:encoded>
<dc:title>Application of principal component analysis to pharmacogenomic studies in Canada</dc:title>
<dc:creator>H Visscher</dc:creator>
<dc:creator>C J D Ross</dc:creator>
<dc:creator>M-P Dubé</dc:creator>
<dc:creator>A M K Brown</dc:creator>
<dc:creator>M S Phillips</dc:creator>
<dc:creator>B C Carleton</dc:creator>
<dc:creator>M R Hayden</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.36</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 362 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>August 4, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.36</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.36</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>362</prism:startingPage>
<prism:endingPage>372</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.36</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.28">
<title>Influence of ethnicity on pharmacogenetic variation in the Ghanaian population</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/WqpqcJzL14I/tpj.2009.28</link>
<content:encoded><![CDATA[
            
<p>
<b>Influence of ethnicity on pharmacogenetic variation in the Ghanaian population</b>
</p>
<p>The Pharmacogenomics Journal 9,
                373 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.28">doi:10.1038/tpj.2009.28</a>
</p>
<p>Authors: J L Yen-Revollo, D J Van Booven, E J Peters, J M Hoskins, R M Engen, H D Kannall, D Ofori-Adjei, H L McLeod
                    &amp; S Marsh</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/WqpqcJzL14I" height="1" width="1"/>]]></content:encoded>
<dc:title>Influence of ethnicity on pharmacogenetic variation in the Ghanaian population</dc:title>
<dc:creator>J L Yen-Revollo</dc:creator>
<dc:creator>D J Van Booven</dc:creator>
<dc:creator>E J Peters</dc:creator>
<dc:creator>J M Hoskins</dc:creator>
<dc:creator>R M Engen</dc:creator>
<dc:creator>H D Kannall</dc:creator>
<dc:creator>D Ofori-Adjei</dc:creator>
<dc:creator>H L McLeod</dc:creator>
<dc:creator>S Marsh</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.28</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 373 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>June 23, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.28</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.28</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>373</prism:startingPage>
<prism:endingPage>379</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.28</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.31">
<title>Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/0DDxcPxyIPY/tpj.2009.31</link>
<content:encoded><![CDATA[
            
<p>
<b>Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese</b>
</p>
<p>The Pharmacogenomics Journal 9,
                380 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.31">doi:10.1038/tpj.2009.31</a>
</p>
<p>Authors: Q Zhou, X M Yu, H B Lin, L Wang, Q Z Yun, S N Hu
                    &amp; D-M Wang</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/0DDxcPxyIPY" height="1" width="1"/>]]></content:encoded>
<dc:title>Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese</dc:title>
<dc:creator>Q Zhou</dc:creator>
<dc:creator>X M Yu</dc:creator>
<dc:creator>H B Lin</dc:creator>
<dc:creator>L Wang</dc:creator>
<dc:creator>Q Z Yun</dc:creator>
<dc:creator>S N Hu</dc:creator>
<dc:creator>D-M Wang</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.31</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 380 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>July 28, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.31</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.31</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>380</prism:startingPage>
<prism:endingPage>394</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.31</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.23">
<title>Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/Ixt01aiuyTY/tpj.2009.23</link>
<content:encoded><![CDATA[
            
<p>
<b>Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening&#63;</b>
</p>
<p>The Pharmacogenomics Journal 9,
                395 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.23">doi:10.1038/tpj.2009.23</a>
</p>
<p>Authors: B Laika, S Leucht, S Heres
                    &amp; W Steimer</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/Ixt01aiuyTY" height="1" width="1"/>]]></content:encoded>
<dc:title>Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?</dc:title>
<dc:creator>B Laika</dc:creator>
<dc:creator>S Leucht</dc:creator>
<dc:creator>S Heres</dc:creator>
<dc:creator>W Steimer</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.23</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 395 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>May 19, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.23</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.23</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>395</prism:startingPage>
<prism:endingPage>403</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.23</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.26">
<title>A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/FpkzbN0hHdI/tpj.2009.26</link>
<content:encoded><![CDATA[
            
<p>
<b>A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms</b>
</p>
<p>The Pharmacogenomics Journal 9,
                404 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.26">doi:10.1038/tpj.2009.26</a>
</p>
<p>Authors: P Gass&#243;, S Mas, M Bernardo, S &#193;lvarez, E Parellada
                    &amp; A Lafuente</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/FpkzbN0hHdI" height="1" width="1"/>]]></content:encoded>
<dc:title>A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms</dc:title>
<dc:creator>P Gassó</dc:creator>
<dc:creator>S Mas</dc:creator>
<dc:creator>M Bernardo</dc:creator>
<dc:creator>S Álvarez</dc:creator>
<dc:creator>E Parellada</dc:creator>
<dc:creator>A Lafuente</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.26</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 404 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>June 9, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.26</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.26</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>404</prism:startingPage>
<prism:endingPage>410</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.26</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/tpj.2009.22">
<title>Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy</title>
<link>http://feeds.nature.com/~r/tpj/rss/current/~3/8XpGHxRa0lE/tpj.2009.22</link>
<content:encoded><![CDATA[
            
<p>
<b>Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy</b>
</p>
<p>The Pharmacogenomics Journal 9,
                411 (December 2009). <a href="http://dx.doi.org/10.1038/tpj.2009.22">doi:10.1038/tpj.2009.22</a>
</p>
<p>Authors: L Lit, F R Sharp, M Apperson, D Z Liu, W L Walker, I Liao, H Xu, B P Ander
                    &amp; B Wong</p>
<img src="http://feeds.feedburner.com/~r/tpj/rss/current/~4/8XpGHxRa0lE" height="1" width="1"/>]]></content:encoded>
<dc:title>Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy</dc:title>
<dc:creator>L Lit</dc:creator>
<dc:creator>F R Sharp</dc:creator>
<dc:creator>M Apperson</dc:creator>
<dc:creator>D Z Liu</dc:creator>
<dc:creator>W L Walker</dc:creator>
<dc:creator>I Liao</dc:creator>
<dc:creator>H Xu</dc:creator>
<dc:creator>B P Ander</dc:creator>
<dc:creator>B Wong</dc:creator>
<dc:identifier>doi:10.1038/tpj.2009.22</dc:identifier>
<dc:source>The Pharmacogenomics Journal 9, 411 (December 2009)</dc:source>
<dc:date>2009-11-18</dc:date>
<prism:publicationName>The Pharmacogenomics Journal</prism:publicationName>
<prism:publicationDate>June 2, 2009</prism:publicationDate>
<prism:doi>10.1038/tpj.2009.22</prism:doi>
<prism:url>http://dx.doi.org/10.1038/tpj.2009.22</prism:url>
<prism:volume>9</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>411</prism:startingPage>
<prism:endingPage>418</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/tpj.2009.22</feedburner:origLink></item>
</rdf:RDF>
